Found 31 matching trials
The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP)
PHASE2TTP is a rare and serious blood disorder, characterized by the formation of...
Location
St Bartholomew's Hospital
Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
PHASE3The purpose of this study is to determine whether plasma exchange as well a...
Location
Cedars-Sinai Medical Center
Plasma Exchange in Acute on Chronic Liver Failure
PHASE3Acute on chronic liver failure (ACLF) is a distinct syndrome in patients wi...
Location
Multiple Locations
Anti-Cytokine Therapy for Vasculitis
PHASE2The purpose of this study is to determine whether Infliximab (monoclonal an...
Location
University Hospitals Birmingham NHS Foundation Trust
Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome
NAThe aim of this study is to evaluate the efficiency and safety of immunoads...
Location
UNIVERSITÄTSMEDIZIN der Johannes Gutenberg-Universität Mainz I. Medizinische Klinik und Poliklinik
Biorepository and Registry for Plasma Exchange Patients
N/APatients who have immune mediated diseases commonly undergo plasma exchange...
Location
DeGowin blood Center
Transplant Antibody-Mediated Rejection: Guiding Effective Treatments
PHASE3This trial evaluates the addition of rituximab to standard of care in the t...
Location
Imperial College London
Plasma Exchange in Covid-19 Patients With Anti-interferon Autoantibodies
PHASE3COVID-19 associated mortality remains high despite the advances in therapeu...
Location
GHU Paris Psychiatrie et Neurosciences
Effect of BM-MSCs on Chronic AMR After Kidney Transplantation
PHASE1This study is designed to investigate the efficacy and safety of allogeneic...
Location
The First Affiliated Hospital, Sun Yat-sen University
An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR
N/AThe aim of this trial is to collect data and provide a better understanding...
Location
Universitätsklinik für Innere Medizin III, Klinische Abteilung für Nephrologie MUW